Subcuticular closure versus dermabond: A prospective randomized trial

Erin F Switzer, Robert C. Dinsmore, James H. North

Research output: Contribution to journalArticle

40 Scopus citations

Abstract

2-Octylcyanoacrylate tissue adhesive (Dermabond™, Ethicon, Inc, Somerville, NJ) is being used successfully for closure of minor lacerations. To date, however, there have been no studies evaluating its use in the operating room for surgical incisions. We conducted a prospective randomized trial to compare the closure of inguinal herniorrhaphy incisions using 2-octylcyanoacrylate tissue adhesive (Dermabond) with closures using 4-0 Monocryl (Ethicon, Inc) in a running subcuticular closure. A total of 46 incisions were randomized at the time of closure. Of these incisions 24 were randomized to Dermabond closure (TA) and 22 were randomized to subcuticular closure (SC). Performance measures included: time for closure, wound complications, and cosmesis. Cosmesis was evaluated by blinded evaluation of photographs of the incisions taken 4 weeks after surgery. Closure times for the TA group were faster than in the SC group (mean of 155 vs 286 seconds; P < 0.001). Wound complications were higher in the TA group (P = 0.045). Cosmesis was also felt to be better in the SC group with a score of 4.2 versus 3.88, but this did not reach statistical significance. Although the use of Dermabond did result in faster wound cultures it also resulted in an increase in wound complications. The difference in mean cosmetic score for each group was not statistically significant but trended toward better scores in the SC group. Based on these findings we do not feel Dermabond is an acceptable alternative to subcuticular suture closure in inguinal herniorrhaphy incisions.

Original languageEnglish (US)
Pages (from-to)434-436
Number of pages3
JournalAmerican Surgeon
Volume69
Issue number5
StatePublished - Dec 1 2003

ASJC Scopus subject areas

  • Surgery

Fingerprint Dive into the research topics of 'Subcuticular closure versus dermabond: A prospective randomized trial'. Together they form a unique fingerprint.

  • Cite this